Fig. 3From: Association between P2Y12 inhibitor reloading and in-hospital outcomes for patients with non-ST-segment elevation acute coronary syndrome already on chronic P2Y12 receptor inhibitors therapy in China: findings from the CCC–ACS (improving care for cardiovascular disease in China-acute coronary syndrome) projectCumulative Kaplan–Meier curve estimates of effectiveness outcomes during the 15 days in hospital period. Survival curves of MACE and major bleeding were illustrated using Kaplan–Meier curves and compared employing log-rank tests. A, B Data for the primary effectiveness outcomes of a major adverse cardiovascular event (MACE) and the primary safety outcomes in the NSTEACS patientsBack to article page